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Abstract: 
Objective: The main aim of this study was to find the 
prevalence of osteoporosis in liver cirrhosis.   
Place and duration of study: This study was carried out 
in Liver clinic or Mayo Hospital Lahore in a duration of 
6 months from December 2018 to May 2019.  
Materials and Methods: 50 patients were selected for 
the study. Both males and females were included in this 
study on random basis. Only those patients were selected 
who were willing to take part in this study. 40 to 70 years 
was the mean age and in all the patients either Hepatitis 
B or C was the reason for cirrhosis of liver. In all the 
patients DEXA scan was obtained and if the T value was 
less than 2.5 it was considered osteoporosis. Informed 
consent was taken from all the patients or their relatives. 
Results: Among the selected 50 patients, 36% were 
females and 64% were male patients. 47 years was the 
mean age of the patients. Osteoporosis was found in 14 
(28%) of the patients. 10 (31.25%) males were affected 
and it was greater than the percentage of female patients. 
Higher incidence was seen in patients with increasing 
age. Incidence was not related to the time duration for 
which the patient had cirrhosis.  
Conclusion: Osteoporosis in case of liver cirrhosis is 
very common and every 4th or 5th patients with cirrhosis 
develops osteoporosis. It is usually neglected and 
considered insignificant. The complications increase with 
the increase in age.  
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Introduction: Fibrotic changes in the normal 
architecture of the liver is defined as cirrhosis 
which is reversible initially but becomes 
irreversible at later stage and ultimately results in 
liver failure. In different phases inflammation and 
regrowth occurs which leads to fibrosis. As these 
processes are irreversible which can result in 
serious health issues and lead to the death of 
patient. Prevalence in different areas of the world is 
different but in underdeveloped countries like 
India, Bangladesh and Pakistan it is higher than 
other countries. Various complications like ascites, 
osteoporosis, encephalopathy, hepatorenal 
syndrome and esophageal varies can develop. 
Osteoporosis caused by cirrhotic liver has been 
ignored in past and treated as a minor complication 
but recently attention has been paid to it as a 
serious complication. Bone mineral density is 
decreased in osteoporosis. According to the studies 
done recently, it has been shown that there is 
higher frequency of demineralization of bones in 
patients with liver cirrhosis as compared to the 
people in which no cirrhosis is seen. Among one 
lac patient almost 20 to 420 patients are affected. 
Factors like age, smoking, female gender, 
decreased sunlight exposure, genetics and other 
factors like drinking habits and diabetes play a 
significant role in the development of osteoporosis. 
Variable cytokines and mediators like fibronectin 
and insulin like growth factors have significant 
impact on the development of diseases but the fact 
that liver cirrhosis is solely responsible for the 
development of osteoporosis is still debatable. For 
measuring bone density, DEXA scan is the most 
commonly used investigation. 26% incidence of 
osteoporosis was reported by Javed M et al in his 
study while Cijevschi C et al reported 38% 
incidence.  
Materials and Methods: 50 patients were selected 
for the study. Both males and females were 
included in this study on random basis. Only those 
patients were selected who were willing to take 
part in this study. 40 to 70 years was the mean age 
and in all the patients either Hepatitis B or C was 
the reason for cirrhosis of liver. In all the patients 
DEXA scan was obtained and if the T value was 
less than 2.5 it was considered osteoporosis. 
Informed consent was taken from all the patients or 
their relatives. 
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Results: Among the selected 50 patients, 36% 
were females and 64% were male patients. 47 years 
was the mean age of the patients. Osteoporosis was 
found in 14 (28%) of the patients. 10 (31.25%) 
males were affected and it was greater than the 
percentage of female patients. Higher incidence 
was seen in patients with increasing age. Incidence 
was not related to the time duration for which the 
patient had cirrhosis. 
Discussion: Portal hypertension, cyanosis, ascites, 
esophageal webs, clubbing and various systemic 
problems can occur due to cirrhosis due to which 
mortality rate is increased. Cirrhosis can lead to 
multiple system failure due to which morbidity and 
mortality is increased. Rate of other related 
complications like decreased sunlight exposure and 
decreased oral intake is also increased that results 
in osteoporosis. In our study, 28% incidence rate of 
osteoporosis associated with cirrhosis is seen which 
is close to other studies where 20-50% incidence 
rate is seen. The results usually vary because of the 
different indicators used for collecting data and the 
method used for measuring density of bone. Bone 
density is usually measured from bone where there 
is high pressure like vertebrae and heel. The use of 
same parameters by Javed M et al revealed the 
same results where he showed 26% incidence. 
With the increasing age, the incidence rate 
increased to 33.3%. The same correlation has been 
shown with age in previous studies. Increasing age 
is the greatest risk for developing osteoporosis.  
Conclusion: Osteoporosis in case of liver cirrhosis 
is very common and every 4th or 5th patients with 
cirrhosis develops osteoporosis. It is usually 
neglected and considered insignificant. The 
complications increase with the increase in age. 
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